The relation between salt intake and high blood pressure has been widely recognized, but its exact mechanisms and the reason of such a relation are not clearly understood. In this review, I discuss the sequence of factors relevant to our understanding of the pathophysiology of ‘essential’ hypertension. I will first consider the relation between two major determinants of systemic blood pressure, i.e. extracellular fluid volume (ECFV) and the renin-angiotensin-aldosterone system, and then the renal sensing mechanism of changes in ECFV, the historical background of salt intake in our culture, and finally suggest explanations of results of genetic analyses of hypertension. The discussion is aimed at furthering our understanding of how and why hypertension develops in response to present day high salt intakes. In addition, data are presented for the implementation of a practical health care policy to effectively reduce the incidence of hypertension.

1.
Rettig R, Unger T: The role of the kidney in the aetiology of hypertension: Renal transplantation studies in rats. Trends Pharmacol Sci 1991;12:243–245.
2.
Kurokawa K: Role of the kidney in the genesis of hypertension: Aberrant renal response to excess salt intake. Clin Exp Pharmacol Physiol 1995;22:S417–S422.
3.
Kurokawa K: Kidney, salt, and hypertension: How and why? Kidney Int 1996;49(suppl 55):S46–S51.
4.
Kurokawa K: Tubuloglomerular feedback: Its physiological and pathophysiological significance. Kidney Int 1998;54(suppl 67):S71–S74.
5.
Schnermann J: Juxtaglomerular cell complex in the regulation of renal salt excretion. Am J Physiol 1998;274:R263–R279.
6.
Skott O, Briggs JP: Direct demonstration of macula densa-mediated renin secretion. Science 1987;237:1618–1620.
7.
Weihprecht H, Lorenz JN, Schnermann J, Skott C, Briggs JP: Effect of adenosine-1-receptor blockade on renin release from rabbit isolated perfused juxtaglomerular apparatus. J Clin Invest 1990;85:1622–1728.
8.
Salomonsson M, Skott O, Persson EG: Lack of effect of intraluminal pressure on renin release from isolated afferent arterioles. Pflügers Arch 1992;421:466–468.
9.
Denton D: Hunger for Salt: An Anthropological, Physiological and Medical Analysis. Berlin, Springer, 1984.
10.
Eaton SB, Konner M: Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med 1985;312:283–289.
11.
Kurokawa K, Okuda T: Genetic and non-genetic basis of essential hypertension: Maladaptation of human civilization to high salt intake. Hypertens Res 1998;21:1–6.
12.
Rossier BC: Cum grano salis: The epithelial sodium channel and the control of blood pressure. J Am Soc Nephrol 1997;8:980–992.
13.
Rotimi C, Puras A, Cooper R, McFarlane-Anderson N, Forrester T, Ogunbiyi O, Morrison L, Ward R: Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension 1996;27:558–563.
14.
Iso H, Harada S, Shimamoto T, Sato S, Kitamura A, Sankai T, Tanigawa T, Iida M, Komachi Y: Angiotensinogen T174M and T235M variants, sodium intake and hypertension among non-drinking, lean Japanese men and women. J Hypertens 2000;18:1197–1206.
15.
Inoue I, Nakajima T, Williams CS, Quackenbusk J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM: A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99:1786–1797.
16.
Kazazian HH Jr: An estimated frequency of endogenous insertional mutations in humans. Nat Genet 1999;22:130.
17.
Eyre-Walker A, Keightley PD: High genomic deleterious mutation rates in hominids. Nature 1999;397:344–347.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.